Biomarkers Consortium – Bone Quality Project
The Problem Patients with osteoporosis, other bone diseases or increased risk for bone fractures have diminished bone strength and quality,...Biomarkers Consortium Cancer Steering Committee Immuno-Oncology Working Group
The Biomarkers Consortium (BC) is issuing a Request For Proposals (RFP) for novel biomarker development to support the mission of the BC Can...Biomarkers Consortium – Sarcopenia 2
The FNIH Biomarkers Consortium Sarcopenia 2 project, Sarcopenia as a Valid Biomarker for Identifying Individuals at Risk of Disability, r...Pre-competitive Analytical Validation of SV2A PET as a Biomarker of Synaptic Density (SV2A PET Project)
The Problem Although researchers have established biomarkers to diagnose Alzheimer’s disease, no biomarker can track cognitive decline ...Non-Invasive Biomarkers of Metabolic Liver Disease (NIMBLE)
The Problem Patients at risk of developing non-alcoholic steatohepatitis (NASH) do not present with symptoms until the disease has advanced...Biomarkers Consortium – Longitudinal Proteomic Changes in CSF from ADNI: Towards Better Defining the Trajectory of Prodromal and Early Alzheimer’s Disease
The Problem Alzheimer’s disease (AD)Researchers lack the tools needed to diagnose pre-symptomatic and early disease, and to predict how/a...Biomarkers Consortium – ctDNA Quality Control Materials Project
The Problem Tumor DNA circulating in bodily fluids offers researchers a valuable tool to study, and thus to treat, cancer. Yet the wide var...Biomarkers Consortium – CSC Scientific Symposium
The Problem cancer research is a large and diverse field, making it difficult to coordinate efforts across its many subfields, which are fo...Diseases
Learn more about the diseases we fight
Partner With Us
Work with the FNIH to accelerate medical breakthroughs for patients